Nutra Pharma Corporation (NPHC) Forms Corporate Alliances that Optimize Its Resources

Nutra Pharma Corp. (OTCQB: NPHC) continues to reach for new heights. A multipurpose biotechnology company, Nutra Pharma markets and delivers Nyloxin and Pet Pain-Away (homeopathic drugs that treat moderate-to-severe chronic pain in humans and pets, respectively) to the over-the-counter pain management market. For 15 years, the company has developed its innovative pipeline of biopharmaceutical products and introduced novel healthcare solutions to the globe. Now, through corporate partnerships with companies like Nationwide Laboratory Services, Nutra Pharma is achieving major milestones operationally.

Nutra Pharma Corporation and Nationwide Laboratories have maintained a facility and personnel sharing agreement since last June. According to this agreement, Nationwide will occupy a section of Nutra Pharma’s production facility in Plantation, Florida, and share its regulatory personnel and capacities with Nutra Pharma. From a facilities viewpoint, this alliance’s advantages go far beyond the surface. By working in unison, the companies can create numerous points of synergy that would drastically improve their use of space and personnel. While Nutra Pharma shares its tangible facility with Nationwide, Nationwide can share its intangible expertise with Nutra Pharma.

A clinical diagnostics laboratory, Nationwide performs routine and specialty human diagnostics. It also offers clinical trial services, such as specimen and special handling requirements. As a result, Nationwide is well-known for its proficiency in structuring and conducting clinical trials. This is a valuable skill set that Nutra Pharma could benefit from while developing orphan drugs in the future. Nationwide also employs top-notch regulatory, quality control and quality assurance employees. They could be helpful to Nutra Pharma as it grows and extends its scope of products.

Nutra Pharma is insistent about growing smartly. The company focuses on growth plans that will shore up its fundamental business and expand its influence into additional markets. Already, the company has developed pain-relief solutions that are both potent and long-lasting but that are also safe for vital organs (e.g. the stomach, liver and kidneys). With millions in America suffering from chronic pain, the search for a lasting cure is clearly a factor in many lives. By offering pain-relief solutions that address record levels of opioid abuse in society, Nutra Pharma is poised to impact a vast global market and take advantage of the subsequent rewards.

For more information on the company, visit www.NutraPharma.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net